Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INCYTE CORP | 16,077 | reported | 15 Jul 2025 | tx 253+2,689,559−2,300,637 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Jul 2025 | TAX_WITHHOLDING | INCYTE CORP | 444 | 69.98 USD | |
| 15 Jul 2025 | TAX_WITHHOLDING | INCYTE CORP | 563 | 68.25 USD | |
| 15 Jul 2025 | GRANT_AWARD | INCYTE CORP | 6,430 | 0.00 USD | |
| 15 Jul 2025 | GRANT_AWARD | INCYTE CORP | 14,472 | 0.00 USD | deriv |
| 15 Jul 2025 | GRANT_AWARD | INCYTE CORP | 16,077 | 0.00 USD | deriv |
| 02 Jul 2025 | TAX_WITHHOLDING | INCYTE CORP | 6,285 | 68.17 USD | |
| 01 Apr 2025 | GRANT_AWARD | INCYTE CORP | 11,159 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | INCYTE CORP | 10,982 | 0.00 USD | |
| 17 Jan 2025 | GRANT_AWARD | INCYTE CORP | 14,772 | 0.00 USD | deriv |
| 09 Dec 2024 | TAX_WITHHOLDING | INCYTE CORP | 873 | 72.11 USD | |
| 15 Jul 2024 | TAX_WITHHOLDING | INCYTE CORP | 549 | 64.25 USD | |
| 15 Jul 2024 | GRANT_AWARD | INCYTE CORP | 7,278 | 0.00 USD | |
| 15 Jul 2024 | GRANT_AWARD | INCYTE CORP | 16,284 | 0.00 USD | deriv |
| 02 Jul 2024 | TAX_WITHHOLDING | INCYTE CORP | 5,560 | 59.02 USD | |
| 14 Feb 2024 | GRANT_AWARD | INCYTE CORP | 7,377 | 0.00 USD | |
| 18 Jan 2024 | GRANT_AWARD | INCYTE CORP | 16,018 | 0.00 USD | deriv |
| 01 Sept 2023 | SALE | INCYTE CORP | 8,449 | 65.13 USD | |
| 14 Jul 2023 | GRANT_AWARD | INCYTE CORP | 7,089 | 0.00 USD | |
| 14 Jul 2023 | GRANT_AWARD | INCYTE CORP | 14,868 | 0.00 USD | deriv |
| 03 Jul 2023 | TAX_WITHHOLDING | INCYTE CORP | 5,783 | 62.08 USD | |
| 20 Jan 2023 | GRANT_AWARD | INCYTE CORP | 4,980 | 0.00 USD | |
| 20 Jan 2023 | GRANT_AWARD | INCYTE CORP | 14,194 | 0.00 USD | deriv |
| 02 Jul 2022 | GRANT_AWARD | INCYTE CORP | 9,921 | 0.00 USD | |
| 05 Jul 2022 | TAX_WITHHOLDING | INCYTE CORP | 2,599 | 79.25 USD | |
| 02 Jul 2022 | GRANT_AWARD | INCYTE CORP | 13,443 | 0.00 USD | deriv |